tiprankstipranks
Aspire Biopharma Holdings (ASBP)
NASDAQ:ASBP
US Market

Aspire Biopharma Holdings (ASBP) Ownership - Who Owns Aspire Biopharma Holdings?

Compare
169 Followers

Aspire Biopharma Holdings (ASBP) Ownership Overview

0.40%0.16%99.45%
0.16% ETFs
99.45% Public Companies and
Individual Investors
The ownership structure of Aspire Biopharma Holdings (ASBP) stock is a mix of institutional, retail, and individual investors. , 0.40% is owned by Insiders, and 99.45% is owned by Public Companies and Individual Investors.
The ownership structure of Aspire Biopharma Holdings (ASBP) stock is a mix of institutional, retail, and individual investors. Approximately 99.60% of the company’s stock is owned by Institutional Investors, 0.40% is owned by Insiders

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 06, 2025
xxxxxxxxxxxxx
$7800

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2025
xxxxxxxxxxxxx
$1308

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
314,336Institution6.26%462,074
20,000Insider0.40%14,360
10,000Institution0.20%7,180
7,859Institution0.16%5,643
1,558Institution0.03%2,290

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
314,336Institution6.26%462,074
1,558Institution0.03%2,290

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
7,859Institution0.16%16,740

FAQ

Who Owns Aspire Biopharma Holdings (ASBP)?
Currently, no data Available
What percentage of Aspire Biopharma Holdings (ASBP) stock is held by institutional investors?
Currently, no data Available
What percentage of Aspire Biopharma Holdings (ASBP) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.45% of Aspire Biopharma Holdings (ASBP) stock is held by retail investors.
    Who owns the most shares of Aspire Biopharma Holdings (ASBP)?
    VANGUARD INDEX FUNDS owns the most shares of Aspire Biopharma Holdings (ASBP).
      What is the significance of the ownership structure for a publicly traded company?
      The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.